Second FDA approved clinical trial in patients with pancreatic cancer and metastatic colorectal18/12/2022
ISK is excited to report the official opening of its second FDA approved clinical trial in the US in patients with pancreatic cancer and metastatic colorectal cancer at Georgetown University in Washington, D.C.